The	the	O	O
ability	ability	O	O
of	of	O	O
insulin	insulin	S_chemicals	O
treatment	treatment	O	O
to	to	O	O
reverse	reverse	O	O
or	or	O	O
prevent	prevent	O	O
the	the	O	O
changes	changes	O	O
in	in	O	O
urinary	urinary	O	B_disease
bladder	bladder	O	I_disease
function	function	O	O
caused	caused	O	O
by	by	O	O
streptozotocin-induced	streptozotocin-induced	O	O
diabetes	diabetes	O	O
mellitus.1	mellitus.1	O	O
.	.	O	O

The	the	O	O
effects	effects	O	O
of	of	O	O
insulin	insulin	S_chemicals	O
treatment	treatment	O	O
on	on	O	O
in	in	O	O
vivo	vivo	O	O
and	and	O	O
in	in	O	O
vitro	vitro	O	O
urinary	urinary	O	B_disease
bladder	bladder	O	I_disease
function	function	O	O
in	in	O	O
streptozotocin-diabetic	streptozotocin-diabetic	O	O
rats	rats	O	O
were	were	O	O
investigated	investigated	O	O
.	.	O	O

2	2	O	O
.	.	O	O
Diabetes	diabetes	O	O
of	of	O	O
2	2	O	O
months	months	O	O
duration	duration	O	O
resulted	resulted	O	O
in	in	O	O
decreases	decreases	O	O
in	in	O	O
body	body	O	B_disease
weight	weight	O	I_disease
and	and	O	O
increases	increases	O	O
in	in	O	O
fluid	fluid	O	O
consumption	consumption	O	O
,	,	O	O
urine	urine	O	O
volume	volume	O	O
,	,	O	O
frequency	frequency	O	O
of	of	O	O
micturition	micturition	O	O
,	,	O	O
and	and	O	O
average	average	O	O
volume	volume	O	O
per	per	O	O
micturition	micturition	O	O
;	;	O	O
effects	effects	O	O
which	which	O	O
were	were	O	O
prevented	prevented	O	O
by	by	O	O
insulin	insulin	S_chemicals	O
treatment	treatment	O	O
.	.	O	O

3	3	O	O
.	.	O	O
Insulin	insulin	S_chemicals	O
treatment	treatment	O	O
also	also	O	O
prevented	prevented	O	O
the	the	O	O
increases	increases	O	O
in	in	O	O
contractile	contractile	O	O
responses	responses	O	O
of	of	O	O
bladder	bladder	O	O
body	body	O	O
strips	strips	O	O
from	from	O	O
diabetic	diabetic	O	O
rats	rats	O	O
to	to	O	O
nerve	nerve	O	O
stimulation	stimulation	O	O
,	,	O	O
ATP	atp	S_chemicals	O
,	,	O	O
and	and	O	O
bethanechol	bethanechol	S_chemicals	O
.	.	O	O

4	4	O	O
.	.	O	O

Diabetes	diabetes	O	O
of	of	O	O
4	4	O	O
months	months	O	O
duration	duration	O	O
also	also	O	O
resulted	resulted	O	O
in	in	O	O
decreases	decreases	O	O
in	in	O	O
body	body	O	B_disease
weight	weight	O	I_disease
,	,	O	O
and	and	O	O
increases	increases	O	O
in	in	O	O
fluid	fluid	O	O
consumption	consumption	O	O
,	,	O	O
urine	urine	O	O
volume	volume	O	O
,	,	O	O
frequency	frequency	O	O
of	of	O	O
micturition	micturition	O	O
,	,	O	O
and	and	O	O
average	average	O	O
volume	volume	O	O
per	per	O	O
micturition	micturition	O	O
,	,	O	O
effects	effects	O	O
which	which	O	O
were	were	O	O
reversed	reversed	O	O
by	by	O	O
insulin	insulin	S_chemicals	O
treatment	treatment	O	O
for	for	O	O
the	the	O	O
final	final	O	O
2	2	O	O
months	months	O	O
of	of	O	O
the	the	O	O
study	study	O	O
.	.	O	O

5	5	O	O
.	.	O	O

Insulin	insulin	S_chemicals	O
treatment	treatment	O	O
reversed	reversed	O	O
the	the	O	O
increases	increases	O	O
in	in	O	O
contractile	contractile	O	O
responses	responses	O	O
of	of	O	O
bladder	bladder	O	O
body	body	O	O
strips	strips	O	O
from	from	O	O
diabetic	diabetic	O	O
rats	rats	O	O
to	to	O	O
nerve	nerve	O	O
stimulation	stimulation	O	O
,	,	O	O
ATP	atp	S_chemicals	O
,	,	O	O
and	and	O	O
bethanechol	bethanechol	S_chemicals	O
.	.	O	O

6	6	O	O
.	.	O	O

The	the	O	O
data	data	O	O
indicate	indicate	O	O
that	that	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
streptozotocin-induced	streptozotocin-induced	O	O
diabetes	diabetes	O	O
on	on	O	O
urinary	urinary	O	B_disease
bladder	bladder	O	I_disease
function	function	O	O
are	are	O	O
both	both	O	O
prevented	prevented	O	O
and	and	O	O
reversed	reversed	O	O
by	by	O	O
insulin	insulin	S_chemicals	O
treatment	treatment	O	O
.	.	O	O

